Frequency of Systolic and Diastolic Dysfunction in Patients Presenting with Liver Cirrhosis Secondary to Hepatis-C at Tertiary Care Hospital, Karachi

Lubna Gul; Rakshanda Jabeen; Ayesha Ejaz; Soniya; Guriya; Muhammad Zubair

doi:10.70749/ijbr.v3i7.1825

Authors

Lubna Gul Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Rakshanda Jabeen Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Ayesha Ejaz Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Soniya Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Guriya Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Muhammad Zubair Department of Medicine Ward 6, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i7.1825

Keywords:

Cirrhotic cardiomyopathy, systolic dysfunction, diastolic dysfunction, liver cirrhosis, echocardiography, Child-Pugh classification.

Abstract

Objective: To determine the frequency of systolic and diastolic dysfunction in patients presenting with liver cirrhosis secondary to hepatis C at Tertiary Care Hospital, Karachi. Methods: This cross-sectional study included 173 patients with liver cirrhosis admitted to a tertiary care hospital. Systolic and diastolic dysfunction were evaluated using echocardiography, with systolic dysfunction defined as an ejection fraction <55% and diastolic dysfunction identified by E/A ratio <1. Clinical parameters, including age, gender, cirrhosis duration, and Child-Pugh classification, were analyzed for their relationship with cardiac dysfunction. Results: Systolic dysfunction was present in 26.6% of patients, while 21.4% exhibited diastolic dysfunction. There were no significant associations between cardiac dysfunction and age, gender, cirrhosis duration, or Child-Pugh classification (p > 0.05). These findings suggest that cardiac dysfunction in cirrhosis develops independently of disease severity. Conclusion: Cirrhotic cardiomyopathy is common and may be underdiagnosed in cirrhotic patients, regardless of clinical severity. Routine cardiac screening, including echocardiography and ECG, should be considered for all cirrhotic patients to detect early dysfunction and prevent complications. Further research is needed to explore long-term outcomes and potential therapeutic strategies.

Downloads

Download data is not yet available.

References

1. Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57:268–78.

https://doi.org/10.1136/gut.2006.112177

2. Sola E, Gines P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53:1135–45.

https://doi.org/10.1016/j.jhep.2010.08.001

3. Martell M, Coll M, Ezkurdia N, Raurell I, Genesca J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol. 2010;2:208–20.

https://doi.org/10.4254/wjh.v2.i6.208

4. Moller S, Krag A, Bendtsen F. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int. 2014;34:1153–63.

https://doi.org/10.1111/liv.12549

5. Al-Hamoudi WK. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol. 2010;16:45–153.

https://doi.org/10.4103/1319-3767.65181

6. Bosch J, Abraldes JG, Fernandez M, Garcia-Pagan JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol. 2010;53:58–567

https://doi.org/10.1016/j.jhep.2010.03.021

7. Garcia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol. 2001;34:50–155.

https://doi.org/10.1016/s0168-8278(00)00006-4

8. Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015 Jan-Mar;28(1):31-40.

https://doi.org/10.1016/j.dld.2015.08.006

9. Stundiene I, Sarnelyte J, Norkute A, Aidietiene S, Liakina V, Masalaite L, Valantinas J. Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review. World J Gastroenterol. 2019 Aug 28;25(32):4779-4795.

https://doi.org/10.3748/wjg.v25.i32.4779

10. Carvalheiro F, Rodrigues C, Adrego T, Viana J, Vieira H, Seco C et al. Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation? Transplant Proc. 2016;48:128–31.

https://doi.org/10.1016/j.transproceed.2016.01.010

11. Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015;21:11502–521.

https://doi.org/10.3748/wjg.v21.i41.11502

12. Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015;28:31–40.

https://doi.org/10.1016/j.dld.2015.08.006

13. Shaikh S, Abro M, Qazi I, Yousfani A. Frequency of cirrhotic cardiomyopathy in patients with cirrhosis of liver: A tertiary care hospital experience. Pak J Med Sci 2011;27(4):44-748.

14. Naqvi R. Epidemiological trends in community-acquired acute kidney injury in Pakistan: 25 years experience from a tertiary care renal unit. Pak J Med Sci. 2021;37(2):312-319.

https://doi.org/10.12669/pjms.37.2.3876

15. Arshad A, Ayaz A. Prevalence of risk factors of acute kidney injury in a tertiary care hospital in Pakistan. J Pak Med Assoc. 2020;70(8):1439-1444.

https://doi.org/10.5455/jpma.20286

16. Bernardi M, Ricci CS, Sica G, et al. Cirrhotic cardiomyopathy: The relationship between liver and heart. World J Gastroenterol. 2020;26(21):2611-2624.

https://doi.org/10.1002/cld.141

17. Wong F. Cirrhotic cardiomyopathy. Hepatol Int. 2009;3(4):515-519.

18. Henriksen JH, Moller S. Cirrhotic cardiomyopathy: Pathogenic mechanisms and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014;11(3):177-186.

https://doi.org/10.1038/nrgastro.2013.210

19. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis. 2007;2:15.

20. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26(5):1131-1137.

https://doi.org/10.1053/jhep.1997.v26.pm0009362352

21. Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57(2):268-278.

22. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut. 2001;49(2):268-275.

https://doi.org/10.1136/gut.49.2.268

23. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Hepatol Int. 2008;2(3):294-304.

24. Myers RP, Lee SS. Cirrhotic cardiomyopathy and hepatorenal syndrome: The heart and kidney in liver failure. J Hepatol. 2005;42(2):19-24.

25. Zardi EM, Zardi DM, Dobrina A, et al. Cirrhotic cardiomyopathy: Pathophysiology and clinical implications. J Hepatol. 2010;53(5):982-990.

https://doi.org/10.1007/978-1-4939-6377-5_35

26. Naschitz JE, Slobodin G, Lewis RJ, et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;140(1):111-120.

https://doi.org/10.1067/mhj.2000.107177

27. Moller S, Bernardi M. Interactions of the heart and liver. Eur Heart J. 2013;34(36):2804-2811.

https://doi.org/10.1093/eurheartj/eht246

28. Moller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. J Hepatol. 2010;53(5):719-729.

https://doi.org/10.1136/gut.2006.112177